OR WAIT null SECS
July 25, 2017
Eli Lilly and Incyte face a roughly 18-month application delay for rheumatoid arthritis drug, baricitinib, in the US with a request from FDA for additional clinical data.
July 24, 2017
Manufacturing capacity will be increased by one third and approximately 300 new high-wage and highly-skilled jobs will be created at the Fremont site.
July 19, 2017
The new center will help biopharmaceutical and pharmaceutical manufacturers with product development.
GSK plans to invest in several UK manufacturing sites and to close its Slough site in conjunction with the sale of the Horlicks brand manufactured in Slough.
July 17, 2017
GSK plans to deliver up to 40 million doses of its quadrivalent flu vaccine for the 2017–2018 season.
July 12, 2017
The company has entered into a settlement agreement with generic-drug companies to resolve patent litigation.
FDA advisory committee has recommended for approval Novartis CAR-T cell therapy CTL019 for the treatment of relapsed and refractory B-cell acute lymphoblastic leukemia in pediatric and young adult patients.
July 11, 2017
The acquisition will add recombinant-based influenza vaccine to Sanofi Pasteur’s portfolio
July 10, 2017
After FDA found a “significant shift in the route of abuse,” Endo voluntarily removes OPANA ER from the market.
July 06, 2017
Fresenius Kabi has added two new antibiotics production lines at its plant in Santiago de Besteiros, Portugal.